Wider Benefits

UKI2S companies have a wider impact on the economy and society:

Healthcare, including drug discovery and medical diagnostics. The Fund has backed a wide range of healthcare companies ranging from gene therapy (ophthalmology and Parkinson’s) through drug development (e.g. prostate cancer) to novel diagnostics and bioinformatics solutions.

Sustainable technologies is another leading area, with companies ranging from green chemicals to a highly ambitious project attempting to fast track fusion energy.

Security and defence – Cobalt Light System’s technology was the leading solution for scanning hand luggage for liquids at airports such as Heathrow, enabling the lifting of the ban imposed after 9/11. Contego’s software is providing part of the security for the high profile Open Banking initiative. P2i’s materials processing technology allowed more breathable battledress with chemical and biological protection.

One company (BGS International, a spin off from the British Geological Survey) contributes to international development, with the Department for International Development (DfID) and the World Bank key customers for their expertise in resource mapping and training. This supports DfID objectives for properly managed exploitation of the mineral and hydrocarbon resources of emerging countries.

 

Latest News

Crescendo Biologics wins in “Life Science Innovation” category at the...

Cambridge, UK, 21 March 2019 – Crescendo Biologics Ltd (Crescendo), the drug developer of...

read more

Eagle Genomics Closes $3.5M Investment

Eagle Genomics closes $3.5M investment, led by the Environmental Technologies Fund Investment to enable...

read more